Safety First Trust Principal-Protected Certificates Linked TO A U.S.-Europe-Japan Basket (AMEX:ATA)
Historical Stock Chart
From Jun 2019 to Jun 2024
Apogee Technology, Inc. (AMEX: ATA), an emerging
nanotechnology and micro-systems company that designs, develops and
commercializes medical devices and sensor products announced today
that Company will present its strategic corporate overview at the
Financial Services Exchange ("FSX") Conference scheduled to take place
at the Omni Royal Orleans Hotel on July 27-29, 2006 in New Orleans,
Louisiana.
With the sponsorship of FSX, regional broker/dealers from across
the United States are brought together with emerging growth companies
to share information and investment opportunities. Founded in 1983,
FSX has hosted quarterly investment meetings for more than 25 years.
About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary
medical device and sensor products using its MEMS and nanotechnology
for the medical, automotive, industrial and consumer markets. The
Company is developing its PyraDerm(TM) solution for enhanced
transdermal drug delivery and has introduced a family of pressure
sensors. Apogee's goal is to provide value-added and cost-savings
solutions for our customers and, in so doing, to become a global
leader in the sensors and medical device field. The Company operates a
worldwide marketing and sales organization with offices in the US and
Japan. For more information please visit our web site at:
http://www.apogeemems.com.
PyraDerm(TM), Sensilica(TM) and BlueSensor(TM) are trademarks of
Apogee Technology, Inc. All other product names noted herein may be
trademarks of their respective holders. Certain statements made herein
that use the words "anticipate," "hope," "estimate," "project,"
"intend," "plan," "expect," "believe" and similar expressions are
intended to identify forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements involve known and unknown risks and
uncertainties, which could cause the actual results, performance or
achievements of the company to be materially different from those that
may be expressed or implied. Please refer to the Company's risk
factors as set forth in the Company's filings with the Securities and
Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.